George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Johnny, time you had your nappy changed...what are you actually here for. Real investors are only interested in posts about the company, not your childish ramblings, so why don't you save that for FLX board.
Moni has lost it. Ring his family at once.
Compassion for a blatant trader? Erm.... nope haha
You naysayers only come out of the woodwork when it suits you. When there's more selling you appear, but when there's more buying you dissappear...Why don't you go join Johnnyy and Stt1 at TLY and FLX instead of boring us to death on here!
Do you know anything about compassion for your fellow human beings? Or do you just dont care? Just felt like I would post on the board you are in my prayers who ever you are . ATB.
Do you know anything about compassion for your fellow human beings? Or do you just dont care? Just felt like I would post on the board you are my prayers who ever you
are . ATB.
So you sold but then expect it to rise when you buy back in? Lol. No one cares
Sold out recently and bought back in again after Mo buying shares and wrongly thought that the selling was possibly starting to dry up. What do I know. ATB.
Hi. The promise for April 2023 was made by Mo in the presentation he did on the final results. At 1 hour and four minutes! Also half year results in July and interims in September. Didn’t understand the last point!
You are right. There are some desperate people around. They seem to be able to read but not understand or retain what they have read. It’s all there in the reports and RNSs
He saw share price didn't he!
Y MONI SO MAD?
As the holder of a significant amount (£200k+) of ORPH shares I have decided to experience FluCamp for myself. I had my first assessment in Manchester last week, which involved giving a blood sample which will be screened for antibodies to determine my eligibility for challenge studies.
The process of signing up via the website was straightforward and user friendly. There were a couple of points which I thought could be approved upon and emailed my observations to Louis Ashe-Jepson at Walbrook. He replied promptly, thanked me and confirmed my comments would be forwarded to the company - I will revisit in a few weeks to check if my suggestions have been actioned.
The assessment itself was highly professional and the staff extremely helpful and friendly. I asked the nurse if they are busy and had a constant supply of volunteers - she replied they are “very busy” and “always have a supply of volunteers”. The clinic was pleasant and well equipped. Each volunteer is paid £40 to cover travel costs for the attending the initial assessment, which was transferred to my bank account within 48 hours. I will hear within the next 3-4 months whether I am eligible for challenge studies.
It has been a smooth process so far and certainly a worthwhile exercise. Volunteers are the lifeblood of challenge studies, so it is most reassuring the company is getting this right.
I will update this board if I am accepted onto a challenge study. Always useful to have feedback from ‘coal face,’ as it were.
Noel - they weren't 'promised' for April, however, there was a stated keenness to get them out earlier. However, CF did state that it is complicated by having foreign operations. In a year when some companies have extended their audit periods due to covid extensions , ORPH has not. ORPH can give a trading update at any time, no need for audited figures BTW.
Of all the areas to bash ORPH and CF people must be getting desperate if they are focusing on the time to publish results, despite it being well within AIM rules.
Johnny and Sickothetech, why don't you stick to posting you ramps on Totally (tly) and Falanx (flx) instead of infecting this board. Good to see both your companies are heading further south again...you're wasting your time here spreading false statements and defamatory remarks about CF...
The results for 2022 have been promised for mid April. This was in response to comments about them not being available until mid June in 2022.
Who's pulling the strings though.
It'll be a long time before there is any sort of evidence of change. The fy2022 results are likely to be published around June 2023 (if previous years are any guidance) and even it'll be early days of prove of any change.
Mo needs several quarters of his comments being backed up by events/contracts etc
Mohammed has to lead from the front. He's wearing Cathels bullet proof vest!
Of course, there are companies which have been going great guns but were in bear market conditions have meant the share price/valuation has not responded appropriately. This is certainly the case with Open Orphan (ORPH), soon to be renamed hVIVO (HVO). We saw the CEO Mo Khan leading from the front https://www.share-talk.com/traders-cafe-with-zak-mir-a-week-in-small-caps-saturday-1st-october-2022/
https://walletinvestor.com/lse-stock-forecast/orph-stock-prediction
Sorry don’t know !
Queen's University is hosting a conference this week on RSV with experts from around the world discussing developments in respiratory illnesses.
https://apple.news/ARzZC4ZMxQjub4kyZKH4i8A
Not sure, any ideas?
Why you think they delayed the RNS Moniman
Well I got a reply from Walbrook PR......."please see the RNS release...."...lol, only took them 2 weeks to catch up with events...:-))
Lol...